Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Enliven Therapeutics

Clinical trials sponsored by Enliven Therapeutics, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New drug cocktail targets Hard-to-Treat HER2 cancers Results expected Jan 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Not yet finished but already full! 1

New drug cocktail targets Hard-to-Treat HER2 cancers

Disease control Ongoing

This early-stage trial is testing a new drug called ELVN-002 in combination with trastuzumab and chemotherapy for people with advanced HER2-positive solid tumors, including breast, gastric, and colorectal cancers. The main goal is to find a safe dose and understand side effects. …

Phase 1 • Sponsor: Enliven Therapeutics • Aim: Disease control

Last updated Jun 27, 2026 07:57 UTC